COMMUNIQUÉS West-GlobeNewswire

Kyverna Therapeutics to Present at Upcoming Investor Conferences
14/05/2026
EMERYVILLE, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a late-stage clinical biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases [...]
Curanex Reports First Quarter 2026 Business Progress as Phyto-N Advances Toward Planned FDA Submission
14/05/2026
Completed GMP manufacturing and toxicology milestones supporting planned Q4 2026 IND submission for ulcerative colitis Expanded pipeline strategy to include cancer cachexia, a serious cancer-associated wasting condition [...]
Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
14/05/2026
~ Achieved First Quarter 2026 Total Net Revenues of $15.1 Million, Up 73% Year Over Year ~ ~ Field Sales Expansion Showing Early Signs of Positive Results with Record PEDMARK ® Demand in April 2026 ~ ~ Initiated Third [...]
Editas Medicine Reports New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at the American Society of Gene and Cell Therapy 2026 Annual Meeting
14/05/2026
New data demonstrate promising preclinical safety profile and durable LDL-C lowering of ≥90% with single dose of EDIT-401 in non-human primates through ~6 months CAMBRIDGE, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- Editas [...]
Topline Results from Phase 2 CELIA Study of Diranersen (BIIB080): First Study to Show Reduction in Tau Pathology and Cognitive Benefit in Patients with Early Alzheimer’s Disease
14/05/2026
CELIA did not meet its primary endpoint assessing dose response; based on the strength of the biomarker and efficacy data, Biogen plans to advance diranersen to registrational development Robust reductions in tau [...]
Ipsen présente la corabotase, un neuro-inhibiteur recombinant (RNI™) « premier de sa classe », lors du symposium SCALE
14/05/2026
La corabotase est la première molécule expérimentale d’une nouvelle classe de neuro-inhibiteurs recombinants, RNI TM , telle que reconnue par l’OMS et l’USAN* Les données de phase II concernant les rides glabellaires ( [...]
Ipsen unveils corabotase, a first-in-class recombinant neuroinhibitor, RNI™, at the SCALE Symposium
14/05/2026
Corabotase is the first investigational molecule in a newly designated class of recombinant neuroinhibitors, RNI TM , as recognized by the WHO and USAN Phase II data in glabellar (frown) lines to be featured as a late- [...]
Propanc Biopharma Implements Reverse Stock Split to Support Continued Nasdaq Listing and Growth Plans
14/05/2026
MELBOURNE, Australia , May 13, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases, [...]
Fangzhou and Tenry Pharmaceutical Forge Strategic Partnership to Advance AI-Powered Chronic Disease Care
14/05/2026
SHANGHAI, May 14, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, and Shanghai Tenry Pharmaceutical Co., Ltd. (“Tenry [...]
JellyTide Claims Evaluated: The Gelatin Trick Recipe + Baking Soda Shot with Lemon for Weight Loss Using Jelly Tide Gummies
14/05/2026
JellyTide Scam or Legit? BHB Salts, Apple Cider Vinegar Gummies, Side Effects, Dosage, and 60-Day Guarantee Explained Largo, FL, May 13, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the Food and [...]
Memopezil Under Investigation: Evaluating the Claims, Risks and Hidden Official Website Complaints about the Natural Donepezil Cocoa and Honey Protocol
14/05/2026
Bacopa Monnieri, Rhodiola Rosea, L-Theanine, and Panax Ginseng in Memopezil Supplement Facts, Refund Policy, Ingredients, and Cognitive Support Claims Explained Largo, FL, May 13, 2026 (GLOBE NEWSWIRE) -- These [...]
IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization
13/05/2026
Progressing toward commercialization with third-party head-to-head data publications and GALACTIC registry study engagement Northeast kidney transplant center (among the top 10 in the U.S.) is first to sign clinical [...]
Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook
13/05/2026
REDWOOD CITY, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced financial results for [...]
Eledon Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Business Highlights
13/05/2026
100% insulin independence achieved in 10 patients with type 1 diabetes treated with tegoprubart following islet transplantation in UChicago Medicine-led study FDA Orphan Drug designation granted to tegoprubart for the [...]
Medicenna Announces the Launch of a Marketed Public Offering of Securities
13/05/2026
NOT FOR DISSEMINATION INTO THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES TORONTO and HOUSTON, May 13, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA), a [...]
Mdxhealth Reports Q1-2026 Results
13/05/2026
Mdxhealth Reports Q1-2026 Results Conference call with Q&A today at 4:30 PM ET / 22:30 CET IRVINE, California – May 13, 2026 ( GlobeNewswire ) – Mdxhealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading [...]
LogicMark, Inc. Announces Strong First Quarter 2026 Results
13/05/2026
Revenue Up 24% as Gross Margin Expands to 69.6% and Operating Loss Narrows LOUISVILLE, Ky., May 13, 2026 (GLOBE NEWSWIRE) -- LogicMark, Inc. (OTC: LGMK) (the “Company”), a provider of personal safety and emergency [...]
Belite Bio to Host Webcast on May 20, 2026, to Discuss First Quarter 2026 Financial Results
13/05/2026
SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Belite Bio , Inc. (NASDAQ: BLTE), (“Belite Bio®” or the “Company”), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics [...]
Glass House Brands Reports First Quarter 2026 Financial Results
13/05/2026
First quarter results include revenue of $40.5 million, average selling price of $171 per pound and biomass production of 152,000 pounds Company reiterates full year 2026 wholesale cannabis biomass production forecast [...]

Pages